ScholarIQanswers from OpenAlex

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype

PaperCitations, authors & open-access status

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype is a paper indexed in ScholarIQ from OpenAlex.

How many citations does EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype have?

ScholarIQcitation count

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype has 389 citations in the OpenAlex counts ScholarIQ stores.

When was EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype published?

ScholarIQyear

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype has 2014 year in the ScholarIQ index.

What is the open-access status of EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype?

ScholarIQoa status

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype has closed oa status in the ScholarIQ index.

What is the DOI of EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype?

ScholarIQdoi

The DOI for EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype is on the source record.

What is the PMID of EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype?

ScholarIQpmid

The PMID for EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype is on the source record.

What is the OpenAlex record for EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype?

ScholarIQopenalex

The OpenAlex for EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial